SFNSATTR

ATTRv-PN: Advances in Understanding and Managing Amyloid Disease with Peripheral Neuropathy

Friday, March 21st from 11:35am - 12:35pm PT

Name:*

First NameLast Name

Credentials:

State Licensed to Practice in:

Email:*

example@example.com

1. Transthyretin is the protein that misfolds causing hereditary amyloidosis. It is produced in which of the following organs?*

2. Amyloid polyneuropathy is most often confused with:*

a. Idiopathic axonal neuropathyb. Myopathyc. Chronic inflammatory demyelinating polyneuropathyd. Mononeuritis multiplex

3. The NEURO-TTRansform study revealed that hATTR-PN patients treated with eplontersen reduced serum TTR by 81%. The root of administration for this novel therapy is:*

a. IV infusionb. Intramuscularc. Subcutaneousd. Oral

Please rate the extent to which this activity met the following objectives:

	Poor	Fair	Good	Very Good	Excellent
Review the accurate and timely diagnosis of ATTRv-PN based on clinical suspicion and guidelines-directed testing strategies.
Understand the pathophysiology of ATTR disease and the mechanistic rationale for new and emerging therapies.
Develop individualized treatment plans for ATTRv-PN based on recent clinical data, patient prognosis, a review of treatment options, an assessment of safety, and shared decision making.

Please provide us with feedback regarding your experience at the activity:

	Poor	Fair	Good	Very Good	Excellent
Overall Program
Content
Usefulness

Please rate the faculty on his overall teaching ability:

	Poor	Fair	Good	Very Good	Excellent
Nivedita Jerath, MD

Do you feel this activity was fair balanced and free of commercial bias?

YesNo

If no, please explain:

This educational activity will result in a change in my role as a healthcare team member.

YesNoN/A

Based on your participation in this activity, choose the statement(s) that applies to how your role as a healthcare team member will change:

I gained new strategies/skills/information that my team can apply to practiceI plan to implement new strategies/skills/information in my practiceI will be more competent in my team’s management of patient careI will improve my communication with the healthcare team

What factors beyond clinical care that effect the health of your patients does your team experience?

courseTitle

credit-amount

Overall Activity Feedback